AZD8233
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for AZD8233, covering 2022-11-18 to 2024-12-24. Get the full timeline:
Most recent: Clinical Trial Update: A Study of AZD8233 in Participants With Dyslipidemia. [Phase 1, Phase 2]